Bipolar disorder

Feasibility of a Symptom Management Intervention for Adolescents Recovering From a Hematopoietic Stem Cell Transplant.

Feasibility of a Symptom Management Intervention for Adolescents Recovering From a Hematopoietic Stem Cell Transplant.

Cancer Nurs. 2013 Jul 9;
Rodgers CC, Krance R, Street RL, Hockenberry MJ

Adolescents undergoing a hematopoietic stem cell transplantation (HSCT) experience a variety… Continue reading →

The Presentation, Recognition and Management of Bipolar Depression in Primary Care.

The Presentation, Recognition and Management of Bipolar Depression in Primary Care.

J Gen Intern Med. 2013 Jul 9;
Cerimele JM, Chwastiak LA, Chan YF, Harrison DA, Unützer J

Bipolar disorder is a mood disorder characterized by episodes of major… Continue reading →

Evaluation of Effect of Allopurinol and Febuxostat in Behavioral Model of Depression in Mice.

Evaluation of effect of allopurinol and febuxostat in behavioral model of depression in mice.

Indian J Pharmacol. 2013 May; 45(3): 244-7
Karve AV, Jagtiani SS, Chitnis KA

To evaluate the effects of allopurinol and febuxostat on depression using Forced… Continue reading →

How Weight Loss and Fat Loss Differs What Are Natural and Effective Ways of Fat Loss?

Question by Miss A: How weight loss and fat loss differs What are natural and effective ways of fat loss?
hey I just heard about this , here’s the only thing I’ve found on it http://www.restaurantandbar.org/fatloss.html does anyone have anymore… Continue reading →

Safety, Anxiety and Natalizumab Continuation in JC Virus-Seropositive MS Patients.

Safety, anxiety and natalizumab continuation in JC virus-seropositive MS patients.

Mult Scler. 2013 Jul 4;
van Rossum JA, Vennegoor A, Balk L, Uitdehaag BM, Polman CH, Killestein J

The use of natalizumab in multiple sclerosis has been restricted by… Continue reading →

Phaeochromocytoma Masquerading as Anxiety and Depression.

Phaeochromocytoma masquerading as anxiety and depression.

Am J Case Rep. 2013; 14: 161-163
Zardawi IM

Patient: Female, 36 Final Diagnosis: Pheochromocytoma Symptoms: Anxiety • depression Medication: – Clinical Procedure: – Specialty: Oncology • endocrinology.Unusual clinical course, Mistake in diagnosis.Pheochromocytoma… Continue reading →

Evidence-Based Guidance for Culturally Sensitive Assessment and Interventions for Perinatal Depression in Black American Women: A Synthesis of Published Research, 2008-2011.

Evidence-based guidance for culturally sensitive assessment and interventions for perinatal depression in black american women: a synthesis of published research, 2008-2011.

J Prim Care Community Health. 2012 Oct 1; 3(4): 278-84
Cruser dA, Asante-Ackuayi L, Brown S, Cardenas E,… Continue reading →

Do You Believe ECT (Electroconvulsive Therapy) Is Effective in Treating Depression?

Question by almintaka: Do you believe ECT (Electroconvulsive Therapy) is effective in treating depression?
In recent years, ECT (Electroconvulsive Therapy) as a treatment for severe depression is being used by a growing number of Psychiatrists. The modern technique includes the… Continue reading →

Whats the Difference Between Bipolar 1 and Bipolar 2?

Question by C-roy: whats the difference between Bipolar 1 and Bipolar 2?
whats the difference between Bipolar 1 and Bipolar 2?

Best answer:

Answer by Kate
Bipolar 1 is characterized by both major depressive and manic phases. Depression includes feelings… Continue reading →

Latent Subtypes of Depression in a Community Sample of Older Adults: Can Depression Clusters Predict Future Depression Trajectories?

Latent subtypes of depression in a community sample of older adults: Can depression clusters predict future depression trajectories?

J Psychiatr Res. 2013 Jun 24;
Hybels CF, Landerman LR, Blazer DG

Identifying sources of heterogeneity in late life depression remains… Continue reading →